Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Nominee Leavitt Says He Will Maintain FDA "Brand" Integrity

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA, NIH and CDC are the three HHS "brands" that act as a seal of quality, safety and good research, Michael Leavitt tells Senate Health confirmation hearing Jan. 18. FDA's goal must be to "inform consumers about risks and benefits," he says.

You may also be interested in...



HHS Nominee Leavitt Wants To "Learn More" About Rx Imports

Michael Leavitt tells Senate Finance Committee during confirmation hearing that he has read "conflicting views" on the economic benefits of drug importation. Leavitt also notes that as HHS Secretary, importation safety issues would fall "squarely" on his desk.

HHS Nominee Leavitt Wants To "Learn More" About Rx Imports

Michael Leavitt tells Senate Finance Committee during confirmation hearing that he has read "conflicting views" on the economic benefits of drug importation. Leavitt also notes that as HHS Secretary, importation safety issues would fall "squarely" on his desk.

Senators Push For Permanent FDA Commissioner At Leavitt Hearing

Senators are urging the Bush Administration to fill the vacancy at the head of the FDA as soon as possible

Topics

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel